Skip to main content

Phreesia, Inc.

PHR
Exchange
NYSE
Industry
Services-Business Services, NEC
SEC CIK
0001412408

In the last 90 days, Phreesia, Inc. insiders filed 0 open-market purchases and 4 sales; 227 institutions reported holding it in 13F filings for Q2 2026, worth $598.3M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Phreesia, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
4 filings
3 insiders, $101.4K in total
Insiders trading
3
Net value
−$101.4K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Phreesia, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Phreesia, Inc.
NameTitleLast reported holdingLast filingFilings, past year
VanDuyn Amy BethSVP, Human Resources260,521Sep 28, 202611
Roberts EvanPresident, Provider Solutions1,038,138Sep 28, 202611
Linetsky DavidPresident, Network Solutions22,267IndirectSep 28, 202616
Indig ChaimChief Executive Officer1,889,595Sep 28, 20268
Hui YvonnePrincipal Accounting Officer64,724Sep 28, 202615
Hoffman Allison CGeneral Counsel & Secretary266,574Sep 28, 202614
Gandhi BalajiChief Financial Officer348,931Sep 28, 20269
Munson GillianDirector66,789Aug 3, 20265
Goldstein LainieDirector70,862Aug 3, 20265
Egbuonu-Davis LisaDirector37,780Jul 16, 20262
Kessler JonDirector43,884Jun 26, 20262
Smith Mark DouglasDirector56,643Jun 26, 20261
Sayar RaminDirector52,725Jun 26, 20261
Cahill Edward LDirector65,613May 4, 20263
Barta Jan10% Owner8,924,329IndirectApr 2, 20262
Pale Fire Capital SE10% Owner8,924,329IndirectApr 2, 20262
Senkypl Dusan10% Owner8,924,329IndirectApr 2, 20262
Pale Fire Capital SICAV a.s.10% Owner8,924,329IndirectApr 2, 20262
Pale Fire Capital investicni spolecnost a.s.10% Owner8,924,329IndirectApr 2, 20262
Weintraub MichaelDirector165,116Aug 27, 20250
Gunzburg JanetPrincipal Accounting Officer34,820Jun 24, 20240
Davidoff Michael J.SVP, Payer Business73,391Jan 18, 20240
Rasmussen RandyChief Financial Officer145,594Feb 6, 20230
Pegus CherylDirector15,825Feb 23, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jan 18, 2024 (view filing)Jan 16-172 daysLinetsky DavidSVP, Life SciencesSSale−33.0K$24.15−$796.4K−13.9%204.1K after2 lots
Jan 18, 2024 (view filing)Jan 16-172 daysHoffman Allison CGeneral Counsel & SecretarySSale−8.92K$24.18−$215.7K−6.1%136.9K after2 lots
Jan 18, 2024 (view filing)Jan 16-172 daysRoberts EvanChief Operating OfficerSSale−43.3K$24.14−$1.05M−5.4%754.5K after2 lots
Jan 18, 2024 (view filing)Jan 16-172 daysIndig ChaimChief Executive OfficerSSale−67.5K$24.14−$1.63M−5.3%1.22M after2 lots
Dec 20, 2023 (view filing)Dec 191 dayGunzburg JanetPrincipal Accounting OfficerSSale−118$23.72−$2.80K−0.3%40.6K after
Dec 20, 2023 (view filing)Dec 18-192 daysLinetsky DavidSVP, Life SciencesSSale−259$23.21−$6.01K−3.3%7.57K after2 lots
Nov 2, 2023 (view filing)Nov 11 dayGunzburg JanetPrincipal Accounting OfficerSSale−298$13.38−$3.99K−0.7%40.7K after
Oct 17, 2023 (view filing)Oct 161 dayDavidoff Michael J.SVP, Payer BusinessSSale−1.20K$16.61−$19.9K−1.3%92.4K after
Oct 17, 2023 (view filing)Oct 161 dayGandhi BalajiChief Financial OfficerSSale−861$16.61−$14.3K−1.0%85.7K after
Oct 17, 2023 (view filing)Oct 161 dayVanDuyn Amy BethSVP, Human ResourcesSSale−665$16.61−$11.0K−0.6%118.1K after
Oct 17, 2023 (view filing)Oct 161 dayHoffman Allison CGeneral Counsel & SecretarySSale−1.30K$16.61−$21.5K−1.1%115.0K after
Oct 17, 2023 (view filing)Oct 161 dayRoberts EvanChief Operating OfficerSSale−1.97K$16.61−$32.7K−0.3%745.9K after
Oct 17, 2023 (view filing)Oct 161 dayLinetsky DavidSVP, Life SciencesSSale−2.08K$16.61−$34.5K−1.0%215.0K after
Oct 17, 2023 (view filing)Oct 161 dayIndig ChaimChief Executive OfficerSSale−3.29K$16.61−$54.7K−0.3%1.24M after
Sep 20, 2023 (view filing)Sep 182 daysGunzburg JanetPrincipal Accounting OfficerSSale−125$19.79−$2.47K−0.3%41.0K after
Sep 20, 2023 (view filing)Sep 182 daysLinetsky DavidSVP, Life SciencesSSale−130$19.67−$2.56K−1.6%7.83K after3 lots
Sep 14, 2023 (view filing)Sep 131 dayRoberts EvanChief Operating OfficerSSale−3.91K$20.34−$79.5K−0.5%747.8K after2 lots
Sep 14, 2023 (view filing)Sep 13-141 dayHoffman Allison CGeneral Counsel & SecretarySSale−5.47K$20.27−$110.8K−4.5%116.3K after3 lots10b5-1
Sep 14, 2023 (view filing)Sep 13-141 dayVanDuyn Amy BethSVP, Human ResourcesSSale−3.83K$20.24−$77.5K−3.1%118.8K after3 lots10b5-1
Sep 14, 2023 (view filing)Sep 131 dayGunzburg JanetPrincipal Accounting OfficerSSale−934$20.34−$19.0K−2.2%41.1K after2 lots
Sep 14, 2023 (view filing)Sep 131 dayGandhi BalajiChief Financial OfficerSSale−3.96K$20.34−$80.5K−4.4%86.5K after2 lots
Sep 14, 2023 (view filing)Sep 13-141 dayDavidoff Michael J.SVP, Payer BusinessSSale−6.56K$20.26−$132.9K−6.6%93.6K after3 lots10b5-1
Sep 14, 2023 (view filing)Sep 131 dayIndig ChaimChief Executive OfficerSSale−6.55K$20.34−$133.3K−0.5%1.25M after2 lots
Sep 14, 2023 (view filing)Sep 131 dayLinetsky DavidSVP, Life SciencesSSale−2.06K$20.34−$41.9K−0.9%217.1K after2 lots
Sep 14, 2023 (view filing)Sep 131 dayLinetsky DavidSVP, Life SciencesSSale−119$20.34−$2.42K−1.5%7.96K after2 lots
Jul 25, 2023 (view filing)Jul 214 daysDavidoff Michael J.SVP, Payer BusinessSSale−1.07K$31.75−$34.1K−1.1%93.6K after10b5-1
May 11, 2023 (view filing)May 101 dayMunson GillianDirectorSSale−3.56K$30.06−$106.9K−15.5%19.3K after10b5-1
Apr 25, 2023 (view filing)Apr 214 daysDavidoff Michael J.SVP, Payer BusinessSSale−1.07K$33.13−$35.6K−1.1%95.8K after10b5-1
Apr 20, 2023 (view filing)Apr 182 daysRoberts EvanChief Operating OfficerSSale−7.45K$32.09−$239.1K−1.0%717.0K after10b5-1
Apr 18, 2023 (view filing)Apr 171 dayVanDuyn Amy BethSVP, Human ResourcesSSale−570$31.84−$18.1K−0.5%119.4K after
Apr 18, 2023 (view filing)Apr 171 dayGandhi BalajiChief Financial OfficerSSale−2.11K$31.83−$67.3K−2.4%85.7K after10b5-1
Apr 18, 2023 (view filing)Apr 171 dayRoberts EvanChief Operating OfficerSSale−2.60K$32.01−$83.2K−0.4%724.4K after10b5-1
Apr 18, 2023 (view filing)Apr 144 daysHoffman Allison CGeneral Counsel & SecretarySSale−3.31K$31.16−$103.0K−2.5%128.3K after10b5-1
Apr 13, 2023 (view filing)Apr 121 dayRoberts EvanChief Operating OfficerSSale−200$32.01−$6.40K0.0%728.8K after10b5-1
Apr 12, 2023 (view filing)Apr 111 dayDavidoff Michael J.SVP, Payer BusinessSSale−3.47K$30.91−$107.1K−3.4%98.0K after10b5-1
Apr 5, 2023 (view filing)Apr 32 daysVanDuyn Amy BethSVP, Human ResourcesSSale−2.98K$30.79−$91.7K−3.0%96.5K after2 lots10b5-1
Apr 5, 2023 (view filing)Apr 32 daysSmith Mark DouglasDirectorSSale−7.00K$30.77−$215.4K−30.3%16.1K after2 lots10b5-1
Feb 6, 2023 (view filing)Feb 24 daysRasmussen RandyChief Financial OfficerSSale−4.76K$40.00−$190.6K−3.2%145.6K after
Feb 6, 2023 (view filing)Feb 24 daysLinetsky DavidSVP, Life SciencesSSale−11.4K$39.55−$450.0K−5.2%205.5K after
Feb 6, 2023 (view filing)Feb 24 daysVanDuyn Amy BethSVP, Human ResourcesSSale−300$40.00−$12.0K−0.3%99.5K after
Feb 6, 2023 (view filing)Feb 24 daysDavidoff Michael J.SVP, Payer BusinessSSale−7.51K$39.21−$294.6K−7.1%98.0K after2 lots
Jan 31, 2023 (view filing)Jan 30-311 dayDavidoff Michael J.SVP, Payer BusinessSSale−31.8K$36.30−$1.15M−23.2%105.5K after3 lots
Jan 20, 2023 (view filing)Jan 182 daysHoffman Allison CGeneral Counsel & SecretarySSale−649$36.07−$23.4K−0.5%129.5K after
Jan 5, 2023 (view filing)Jan 32 daysRoberts EvanChief Operating OfficerSSale−10.0K$31.35−$313.5K−1.4%703.7K after3 lots
Dec 21, 2022 (view filing)Dec 201 dayVanDuyn Amy BethSVP, Human ResourcesSSale−378$33.73−$12.7K−0.4%87.0K after
Dec 15, 2022 (view filing)Dec 13-142 daysHoffman Allison CGeneral Counsel & SecretarySSale−3.91K$34.73−$135.8K−3.7%102.3K after2 lots
Dec 15, 2022 (view filing)Dec 132 daysLinetsky DavidSVP, Life SciencesSSale−11.4K$34.61−$393.8K−5.8%185.5K after
Dec 13, 2022 (view filing)Dec 94 daysLinetsky DavidSVP, Life SciencesSSale−26.8K$29.78−$799.2K−12.0%196.9K after
Dec 13, 2022 (view filing)Dec 9-124 daysRasmussen RandyChief Financial OfficerSSale−17.3K$30.98−$536.8K−13.8%108.5K after3 lots
Nov 4, 2022 (view filing)Nov 22 daysVanDuyn Amy BethSVP, Human ResourcesSSale−19.3K$26.83−$519.0K−21.1%72.4K after3 lots